Immediate Impact

63 standout
Sub-graph 1 of 24

Citing Papers

Semaglutide and walking capacity in people with symptomatic peripheral artery disease and type 2 diabetes (STRIDE): a phase 3b, double-blind, randomised, placebo-controlled trial
2025 Standout
Antibiotic pollution and associated antimicrobial resistance in the environment
2024 Standout
2 intermediate papers

Works of Effie Kuti being referenced

Assessing risk of future cardiovascular events, healthcare resource utilization and costs in patients with type 2 diabetes, prior cardiovascular disease and both
2020
Length of Stay and Hospital Costs Associated with a Pharmacodynamic‐Based Clinical Pathway for Empiric Antibiotic Choice for Ventilator‐Associated Pneumonia
2010

Author Peers

Author Last Decade Papers Cites
Effie Kuti 120 56 55 94 62 23 309
Glenn Magee 89 42 34 74 64 15 360
Anne Rossel 98 21 41 38 89 14 293
Emily C. Welch 118 12 34 38 65 14 336
Eva Susanne Dietrich 128 26 17 61 31 21 362
Tanya R. Flohr 129 10 68 79 68 22 348
Verena Schneider‐Lindner 105 49 20 23 40 23 299
Way Huey 86 67 8 66 56 8 274
Emanuela Santoro 51 23 62 23 40 26 290
Dipu T Sathyapalan 68 18 26 31 40 40 290
Laurajo Ryan 155 34 11 68 27 18 326

All Works

Loading papers...

Rankless by CCL
2026